Bausch Health (BHC)
(Delayed Data from NYSE)
$8.18 USD
+0.16 (2.00%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $7.83 -0.35 (-4.28%) 6:48 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Income Statements
Fiscal Year end for Bausch Health Cos Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 8,757 | 8,124 | 8,434 | 8,027 | 8,601 |
Cost Of Goods | 2,559 | 2,364 | 2,394 | 2,249 | 2,350 |
Gross Profit | 6,198 | 5,760 | 6,040 | 5,778 | 6,251 |
Selling & Adminstrative & Depr. & Amort Expenses | 5,235 | 5,306 | 5,590 | 5,102 | 6,454 |
Income After Depreciation & Amortization | 963 | 454 | 450 | 676 | -203 |
Non-Operating Income | -25 | 881 | -48 | -76 | -22 |
Interest Expense | 1,328 | 1,464 | 1,426 | 1,534 | 1,612 |
Pretax Income | -390 | -129 | -1,024 | -934 | -1,837 |
Income Taxes | 221 | 83 | -87 | -375 | -54 |
Minority Interest | -19 | 13 | 11 | 1 | 5 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -611 | -212 | -937 | -559 | -1,783 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -592 | -225 | -948 | -560 | -1,788 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2,292 | 1,947 | 2,057 | 2,562 | 1,935 |
Depreciation & Amortization (Cash Flow) | 1,329 | 1,493 | 1,607 | 1,886 | 2,138 |
Income After Depreciation & Amortization | 963 | 454 | 450 | 676 | -203 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 365.43 | 362.90 | 359.09 | 354.43 | 351.97 |
Diluted EPS Before Non-Recurring Items | 3.49 | 3.06 | 4.46 | 3.99 | 4.43 |
Diluted Net EPS (GAAP) | -1.62 | -0.62 | -2.64 | -1.58 | -5.08 |
Fiscal Year end for Bausch Health Cos Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,403.00 | 2,153.00 | 2,408.00 | 2,238.00 | 2,167.00 |
Cost Of Goods | 719.00 | 640.00 | 705.00 | 623.00 | 649.00 |
Gross Profit | 1,684.00 | 1,513.00 | 1,703.00 | 1,615.00 | 1,518.00 |
SG&A, R&D, and Dept/Amort Expenses | 1,295.00 | 1,232.00 | 1,354.00 | 1,601.00 | 1,106.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 389.00 | 281.00 | 349.00 | 14.00 | 412.00 |
Non-Operating Income | 9.00 | 5.00 | -6.00 | -1.00 | -14.00 |
Interest Expense | 350.00 | 355.00 | 363.00 | 339.00 | 319.00 |
Pretax Income | 48.00 | -69.00 | -7.00 | -326.00 | 79.00 |
Income Taxes | 49.00 | 8.00 | 40.00 | 56.00 | 52.00 |
Minority Interest | -11.00 | -13.00 | -8.00 | -4.00 | 1.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.00 | -77.00 | -47.00 | -382.00 | 27.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 10.00 | -64.00 | -39.00 | -378.00 | 26.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 370.20 | 376.47 | 354.54 | 366.99 | 371.43 |
Diluted EPS Before Non-Recurring Items | 0.89 | 0.59 | 1.15 | 1.03 | 0.81 |
Diluted Net EPS (GAAP) | 0.03 | -0.17 | -0.11 | -1.03 | 0.07 |